Recent

% | $
Quotes you view appear here for quick access.

Qorvo, Inc. Message Board

mkody1 19 posts  |  Last Activity: Feb 3, 2016 10:43 PM Member since: Sep 23, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Bullish Engulfing

    by mkody1 Feb 1, 2016 9:53 PM
    mkody1 mkody1 Feb 3, 2016 10:43 PM Flag

    BUY confirmed, smooth sail to $4.20....!

    Sentiment: Strong Buy

  • Reply to

    Sooner or later

    by schagcscha Feb 1, 2016 1:34 PM
    mkody1 mkody1 Feb 3, 2016 12:05 PM Flag

    Sooner!.....$4

    Sentiment: Strong Buy

  • Look for Edap to make a nice run just before the earnings come out.

    Sentiment: Strong Buy

  • Is a matter of when not if.....!!

    Sentiment: Strong Buy

  • Reply to

    Edap, oversold by 200%

    by brooksal93 Jan 22, 2016 11:57 AM
    mkody1 mkody1 Jan 22, 2016 2:16 PM Flag

    monti,
    "GE Medical is their only option"
    GE is an option but not their "only" option......jmo

    Sentiment: Strong Buy

  • Reply to

    Extreme bear market

    by hvisklat Jan 15, 2016 2:39 PM
    mkody1 mkody1 Jan 15, 2016 3:45 PM Flag

    -I know you mean the recent uptrend. 1 month 100% approximatly.
    yep, you got that right.

    Sentiment: Strong Buy

  • Reply to

    Extreme bear market

    by hvisklat Jan 15, 2016 2:39 PM
    mkody1 mkody1 Jan 15, 2016 3:28 PM Flag

    Look at Amsc......Edap will do the same.....up up up and way up.

    Sentiment: Strong Buy

  • Reply to

    Edap, coiled and ready.

    by brooksal93 Jan 13, 2016 5:04 PM
    mkody1 mkody1 Jan 14, 2016 11:52 AM Flag

    We're very close to the "boom buy" signal here.......oversold, for sure a double in 90 days.

    Sentiment: Strong Buy

  • He is done selling.

    Sentiment: Strong Buy

  • Reply to

    Edap, 50% below all time high,

    by mkody1 Jan 11, 2016 3:14 PM
    mkody1 mkody1 Jan 11, 2016 3:28 PM Flag

    50% of recent high, pardon me!

    Sentiment: Strong Buy

  • why, I don't know?

    Sentiment: Strong Buy

  • Reply to

    Option CALL open interest is too high

    by j0hn_chambers Dec 3, 2015 5:32 PM
    mkody1 mkody1 Dec 3, 2015 5:36 PM Flag

    So, your first post here and you say what?

    Sentiment: Strong Buy

  • S&P posts biggest drop since September as ECB disappoints
    Reuters
    15 minutes ago
    
    Traders work on the floor of the New York Stock Exchange
    .
    View photo
    Traders work on the floor of the New York Stock Exchange December 1, 2015. REUTERS/Brendan McDermid

    By Caroline Valetkevitch

    Related Stories

    US STOCKS-Wall St lower as ECB stimulus seen not dovish enough Reuters
    US STOCKS SNAPSHOT-Wall St opens higher after Fed minutes, jobs data Reuters
    Wall Street eases as consumer, healthcare stocks lag Reuters
    GLOBAL MARKETS-Dollar strengthens after data, Yellen eyed Reuters
    Yellen comments boost dollar, stocks fall Reuters
    Ouch! Top 30 Knockouts Captured in MMA politicsparadise.com Sponsored 
    (Reuters) - The S&P 500 suffered its biggest drop since late September on Thursday as the European Central Bank disappointed market hopes for greater stimulus.

    The ECB move triggered a spike in the euro (EUR=) that caught investors by surprise, forcing them to shift positions that hit most asset classes. Bond prices dropped after the announcement.

    At the same time, the CBOE Volatility index (.VIX), the stock market's fear gauge, jumped 13.8 percent, closing at its highest since Nov. 17.

    The ECB cut its deposit rate deeper into negative territory and extended its asset buys by six months, as expected. But some market participants had hoped for greater stimulus.

    All 10 S&P 500 sectors fell in a second day of sharp losses for U.S. stocks. Healthcare (.SPXHC) ended down 2.2 percent, leading the day's decline in the S&P 500, followed by energy (.SPNY), down 2 percent.

    "The biggest influence was the (ECB President Mario) Draghi talk this morning; it didn't satisfy the U.S. markets," said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.

    Federal Reserve Chair Janet Yellen's comments suggested the Fed was on track to raise interest rates this month.

    Yellen told lawmakers the U.S. central bank was close to lifting its overnight interest rate from near zero. She gave an upbeat view of the economy, saying "growth is likely to be sufficient over the next year or two to result in further improvement in the labor market." The Fed's next policy meeting is on Dec. 15-16.

    The Dow Jones industrial average (.DJI) fell 252.01 points, or 1.42 percent, to 17,477.67, the S&P 500 (.SPX) lost 29.89 points, or 1.44 percent, to 2,049.62 and the Nasdaq Composite (.IXIC) dropped 85.70 points, or 1.67 percent, to 5,037.53.

    The S&P 500 posted its biggest daily percentage decline since Sept. 28 and closed at its lowest since Nov. 13.

    Some of the selling was related to leveraged funds that were likely forced to close positions as volatility spiked. According to Bank of America research, these funds, which were heavily involved in the dramatic selloff in late August, have since returned to the level of leverage they had prior to that downturn.

    Volume was elevated in S&P 500 index options expiring on Friday, particularly in put options that suggest people were hedging against the possibility of losses, said Henry Schwartz, president of options analytics firm Trade Alert, in New York.

    "After a really slow week it does look like hedgers are taking some action today," he said.

    Data released on Thursday showed initial U.S. jobless claims for last week rose but remained at levels consistent with a strengthening labor market. Friday's employment report is expected to show the U.S. economy added 200,000 jobs in November.

    Zafgen (ZFGN.O) shares were down 5.1 percent at $5.96 after the company said the U.S. Food and Drug Administration was putting on complete hold a late-stage study testing its experimental obesity drug.

    Declining issues outnumbered advancing ones on the NYSE by 2,518 to 579, for a 4.35-to-1 ratio on the downside; on the Nasdaq, 2,159 issues fell and 674 advanced for a 3.20-to-1 ratio favoring decliners.

    The S&P 500 posted 9 new 52-week highs and 26 new lows; the Nasdaq recorded 53 new highs and 78 new lows.

    Sentiment: Strong Buy

  • Reply to

    What just happened?

    by dprstocks13 Nov 24, 2015 11:08 AM
    mkody1 mkody1 Nov 24, 2015 11:12 AM Flag

    Read the new article just came out this morning.....this is about to bust out in a big way.....look out if we hit $7. Maybe new orders coming soon?

    Sentiment: Strong Buy

  • Positive Outcomes From Prostate Cancer Hemiablation Study With EDAP Ablatherm Robotic HIFU Presented at 109th French Urology Congress
    EDAP TMS SA
    1 minute ago
    GlobeNewswire
    

    LYON, France, Nov. 24, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, today announced data from a multicenter trial demonstrating encouraging outcomes of focal HIFU as a new treatment strategy for patients with unilateral localized prostate cancer.

    The dataset was presented in a poster session during the 109th French Urology Congress, held November 18-21, 2015 in Paris, France.

    Data from the abstract, entitled "Focal HIFU (High Intensity Focused Ultrasound) treatment of unilateral localized prostate cancer -- Hemiablation strategy: a prospective French multicentric study with 111 patients," demonstrated the potential of hemiablation (removal of half the prostate) using focal HIFU to achieve a local control of the tumor in patients with unilateral prostate cancer.

    The study, which was conducted at 10 centers throughout France, was sponsored and designed by the French Urological Association (AFU). The aim of the study was to assess the effectiveness and side effect profile of prostatic hemiablation using Ablatherm HIFU to treat the pathologically affected lobe.

    Pascal Rischmann, Professor and Chairman, Department of Urology, Rangueil University, Principal Investigator of the trial and President of 109th French Urology Congress commented, "The data from the trial are highly encouraging in comparison to other existing treatments: 88% of the study patients showed no significant findings on biopsy after Focal HIFU, while 97% of patients maintained continence and 78% retained sexual function. We believe that hemiablation HIFU will be an attractive treatment option for many patients."

    Pierre Reboul, France Business Unit Director, added: "We had a strong presence throughout this year's AFU Congress, which was well attended by members of the French urology community. There was clearly a growing interest in HIFU technology for the management of localized prostate cancer, which we believe was supported by the French authorities' decision to reimburse HIFU at the same rate as surgery. At this annual event, we further established EDAP as the leading company in therapeutic ultrasound with a complete urology offering in stone and prostate disease management."

    Related Quotes
    EDAP
    5.70
    +3.64%
    EDAP TMS SA In Watchlist
    5.70+0.20(3.64%)
    NASDAQ11:01 AM EST

    Q3 2015 Edap Tms SA Earnings Release - After Market Close CCBN 6 days ago
    Evolent Q3 Loss Narrower than Expected; Revenues Rise Y/Y Zacks 15 days ago
    More
    Marc Oczachowski, EDAP TMS Chief Executive Officer, concluded: "This study is another excellent clinical paper from Ablatherm users and experts; these data complement the already comprehensive clinical background of Ablatherm-HIFU, confirming its best-in-class capabilities in prostate tissue ablation."

    Sentiment: Strong Buy

  • Reply to

    Edap is going to $30.

    by brooksal93 Nov 23, 2015 8:44 PM
    mkody1 mkody1 Nov 24, 2015 10:25 AM Flag

    Lets see, some people have a problem with with your post. Edap isn't supposed to get any new orders until they say so, oh, who cares Edap is heading up and will get new orders soon. Long and strong Edap!

    Sentiment: Strong Buy

  • 10/30/2015 1,301,120
    10/15/2015 1,157,294
    Sooner or later we will that pow to $10+...:-)

    Sentiment: Strong Buy

  • They (shorts) tried and failed today. Bravo to the management of Edap. The future looks great. Tomorrow OE.

    Sentiment: Strong Buy

  • 3 DAY CHART ALERT 10, Strong bullish 3 day chart pattern.

    10, Extreme 3 day accumulation, occurs 5% of the time.
    Days BackStrong BullishMild BullishNeutralMild BearishStrong Bearish05101525 Show 2 Day Avg
    3 Day Chart Alert (over last 25 days)

    MONEYFLOW 9, Extreme Neutral 1 day moneyflow,
    stalemate between bulls and bears, occurs 10% of the time.

    BREAKOUT WATCH for breakout above $5.95, no resistance in area just above.
    Type: True breakout from double resistance.
    Target: $7.08, 27.6% Stop: $5.11 Loss: 7.9% P/L ratio: 3.5 : 1 - Excellent

    Sentiment: Strong Buy